Ionis Pharmaceuticals Inc
IONS
Revenue
225.25M
▲105.75M▲88.50%
3 Months ChangeAssets
2.69B
▼-72.80M▼-2.63%
3 Months ChangeLiabilities
2.43B
▼-39.98M▼-1.62%
3 Months ChangeFree Cash Flow
-154.43M
▼-9.97M▼-6.90%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-12
Form 8-K
ID: 0001193125-24-217333
2024-09-09
Form 8-K
ID: 0001193125-24-215939
2024-08-01
Form 10-Q
ID: 0000874015-24-000187
2024-08-01
Form 8-K
ID: 0001140361-24-035233
2024-06-18
Form 8-K
ID: 0001140361-24-030447
2024-06-10
Form 8-K
ID: 0001140361-24-029588
2024-05-31
Form 8-K
ID: 0001140361-24-028247
2024-05-07
Form 10-Q
ID: 0000874015-24-000142
2024-05-07
Form 8-K
ID: 0001140361-24-024648
2024-04-08
Form 8-K
ID: 0001140361-24-018449